IPO Issue Details
Issue Price / Price Band₹15 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size8,000 Shares per Lot
Total Issue Size10,24,000 shares (aggregating up to ₹1.54 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenFri, 29 Jan 2016
Subscription CloseTue, 09 Feb 2016
Anchor AllotmentThu, 28 Jan 2016
Basis of AllotmentMon, 15 Feb 2016
Initiation of RefundsTue, 16 Feb 2016
Credit of Shares to DematTue, 16 Feb 2016
Listing DateMon, 22 Feb 2016
UPI Mandate Deadline2016-02-09
Application & Investment Details
Retail — Min (1 Lots)₹1,20,000 — 8,000 shares
Retail — Max (13 Lots)₹1,560,000 (13 Lots)
HNI — Min (2 Lots)₹2,40,000 — 16,000 shares
Pre-IPO Promoter Holding30,37,500 shares
Post-IPO Promoter Holding4,06,15,000 shares
About Ganga Pharmaceuticals Ltd.
Incorporated in 1994, Ganga Pharmaceuticals Ltd (GPL) is engaged in production of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines all over Maharashtra.Company is manufacturing the following proprietary products:1) Ampachan Vati;2) Khadira Vati;3) Nirmalaya churnaCompany's products are available in liquid dosage form and solid dosage forms. Liquid dosage form includes Oil-based products and solid dosage forms includes Powder-based products, Tablets, and Pills.
Objects of the Issue
Ganga Pharmaceuticals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Deployment of production capacity
0.25
2
2 Marketing and Brand Building
0.70
3
3 General Corporate Purpose
0.30
Shareholding & Lock-in
Pre-IPO Promoter Holding
30,37,500 shares
Post-IPO Promoter Holding
4,06,15,000 shares